CA-REZZ - NORISC - INCONTINENT WASH (BENZETHONIUM CHLORIDE) SOLUTION [FNC MEDICAL CORPORATION]

CA-REZZ - NORISC - INCONTINENT WASH (BENZETHONIUM CHLORIDE) SOLUTION [FNC MEDICAL CORPORATION]
PDF | XML

NDC 60762-113-08
Set ID ed26fa74-5ae8-4294-b61d-682d6ad4b32a
Category HUMAN OTC DRUG LABEL
Packager FNC MEDICAL CORPORATION
Generic Name
Product Class
Product Number
Application Number PART333A
  • ACTIVE INGREDIENT

    BENZETHONIUM CHLORIDE 0.12%

  • PURPOSE

    ANTIBACTERIAL

  • USES

    CA-REZZ NORSIC WASH HAS BEEN FORMULATED AS AN INCONTINENT WASH TO QUICKLY EMULSIFY BODY WASTE EVEN IN THE MOST SENSITIVE PERINEAL AREAS.

    CA-REZZ NORSIC WASH IS PH BALANCED AND ENRICHED WITH ALOE VERA, TO SOOTHE AND HELP PROMOTE HEALING OF FRAGILE, IRRITATED SKIN. STOPS ODORS.

  • WARNINGS

    FOR EXTERNAL USE ONLY. IF RASH OR IRRITATION DEVELOP, DISCONTINUE USE. CONSULT A PHYSICIAN IF IRRITATION PERSISTS.

  • KEEP OUT OF REACH OF CHILDREN

    KEEP OUT OF REACH OF CHILDREN.

  • DIRECTIONS

    1. SPRAY CA-REZZ NORSIC WASH WHERE URINE, FECES OR EMESIS HAS SOILED SKIN PAD LINENS AND CLOTHING.
    2. REMOVE BULK OF FECES OR EMESIS.
    3. SPRAY ADDITIONAL CA-REZZ NORSIC WASH ON WARM WET CLOTH. CLEANSE SKIN OF ALL REMAINING RESIDUE. PAT DRY. NOTE: IF AREA NEEDING CARE IS SIZEABLE AND FECAL OR EMESIS MATERIAL MASSIVE, RINSING IS ADVISED.
    4. ADD ONE CAPFUL OF CA-REZZ NORSIC WASH TO THE REGULAR LAUNDRY TO ELIMINATE RESIDUAL ODORS.
  • OTHER INFORMATION

    CA-REZZ NORSIC WASH IS ENRICHED WITH ALOE.

  • INGREDIENTS

    DEIONIZED WATER, SODIUM LAURETH SULFATE, PROPYLENE GLYCOL, DISODIUM COCOAMPHODIACETATE, POLYSORBATE 80 (AND) CETYL ALCOHOL (AND) ACETYLATED LANOLIN ALCOHOL, ALOE VERA EXTRACT, CITRIC ACID, PHENOXYETHANOL, ETHYHEXYLGLYCERIN, D&C YELLOW #10, FRAGRANCE.

  • QUESTIONS OR COMMENTS?

    PLEASE CALL 1-800-440-2888

  • PRINCIPAL DISPLAY PANEL

    Incontinent Wash_8oz_LBL

  • INGREDIENTS AND APPEARANCE
    CA-REZZ - NORISC - INCONTINENT WASH 
    benzethonium chloride solution
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:60762-113
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    BENZETHONIUM CHLORIDE (UNII: PH41D05744) (BENZETHONIUM - UNII:1VU15B70BP) BENZETHONIUM CHLORIDE0.12 g  in 100 mL
    Inactive Ingredients
    Ingredient NameStrength
    WATER (UNII: 059QF0KO0R)  
    SODIUM LAURETH SULFATE (UNII: BPV390UAP0)  
    PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
    DISODIUM COCOAMPHODIACETATE (UNII: 18L9G3U51M)  
    POLYSORBATE 80 (UNII: 6OZP39ZG8H)  
    CETYL ACETATE (UNII: 4Q43814HXS)  
    ACETYLATED LANOLIN ALCOHOLS (UNII: SNN716810P)  
    ALOE VERA WHOLE (UNII: KIZ4X2EHYX)  
    ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)  
    PHENOXYETHANOL (UNII: HIE492ZZ3T)  
    ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)  
    D&C YELLOW NO. 10 (UNII: 35SW5USQ3G)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:60762-113-08237 mL in 1 BOTTLE, SPRAY; Type 0: Not a Combination Product02/05/2018
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC monograph not finalpart333A02/05/2018
    Labeler - FNC MEDICAL CORPORATION (849207519)
    Registrant - FNC MEDICAL CORPORATION (849207519)
    Establishment
    NameAddressID/FEIBusiness Operations
    FNC MEDICAL CORPORATION849207519label(60762-113) , manufacture(60762-113)